All posts

Three cinema stocks reviewed by Roth

Going to the movies is still proving to be a tough sell these days, but the industry just posted the best quarter in the post-pandemic era, although numbers are still off from 2019 highs. In an entertainment industry report on Monday, Roth Capital Partners analyst Eric Handler reviewed the latest results and coming attractions from the cinema market and reiterated a “Buy” rating on one stock, IMAX, while giving “Neutral” and “Sell” ratings to two others.

No fireworks were on display in the industry second quarter numbers, where preliminary box office results were $2.680 billion, which was up 15.2 per cent year-over-year and matched Handler’s estimate at the same $2.68 billion.

“The pre-holiday weekend proved underwhelming with the Top Ten movies grossing $118 million, down 37 per cent year-over-year and down 15 per cent versus the same period in 2019,” Handler wrote.

The good news was that the Q2 was the industry’s best of the post-pandemic period, with June delivering the second-best post-pandemic month at $1.0 billion and trailing only July of last year at $1.13 billion.

At the same time, Handler noted a trend where revenue from beyond the Top Ten is looking scarce. The quarter saw Top Ten films averaging revenue of $215 million, up 2.5 per cent compared to the averages in the years 2015-19, but after that, revenue from the films ranked #11-20 and #21-30 was $30 million and $11 million, respectively, representing drops of 38 per cent and 52 per cent respectively compared to 2015-19 numbers.

“This data suggests moviegoers, in general, have interest in returning to theatres for top films with visuals and experiences that cannot be replicated at home,” Handler wrote. “In contrast, mid-level movies are having a tougher time, which could be a function of quality, but more likely, consumers are taking advantage of either shortened windows or are able to find acceptable substitutes from their SVOD services.”

Handler said franchises and horror movies are performing the best, while adult dramas and comedies are lagging.

Focusing on IMAX, Handler said the global box office for its network over the holiday weekend was roughly $15 million, with Indiana Jones and the Dial of Destiny leading the way with $11 million worldwide. Handler said IMAX should have better days ahead with the release of major pictures Mission: Impossible – Dead Reckoning Part 1 on July 12 and Oppenheimer on July 21, along with China local language fantasy movie Creation of the Gods I: Kingdom of Storms on July 20.

“Despite the weaker than anticipated 2Q results, we remain pleased with how blockbuster films are generally performing across IMAX’s global network, its rising market share, and the recovery of the Chinese box office (+153 per cent year-over-year in 2Q23 and +116 per cent year-to-date). In addition, the resurgence of demand for IMAX system installations by theatres has been a welcome sight,” he said.

Stock: IMAX (IMAX Stock Quote, Charts, News, Analysts, Financials NYSE:IMAX)

Roth Capital Rating: Buy

Roth Target Price: $26

Projected Return to Target: 53 per cent

Stock: AMC Entertainment (AMC Entertainment Stock Quote, Charts, News, Analysts, Financials NYSE:AMC)

Roth Capital Rating: Sell

Roth Target Price: $0.50

Projected Return to Target: -89 per cent

Stock: Cinemark (Cinemark Stock Quote, Charts, News, Analysts, Financials NYSE:CNK)

Roth Capital Rating: Neutral

Roth Target Price: $18

Projected Return to Target: 9 per cent

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: amccnximax
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Uber stock a buy? (May, 2024)

Following the release of the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on… [Read More]

1 day ago

Trulieve scores price target raise at Echelon

Following the company's most recent results, Echelon Capital Markets analyst Andrew Semple has raised his price target on Trulieve Cannabis… [Read More]

1 day ago

Is Green Thumb Industries a buy? (May, 2024)

Its first quarter numbers are in the books and Beacon Securities analyst Russell Stanley is still bullish on Green Thumb… [Read More]

2 days ago

Is TKO stock a buy?

Following the company's first quarter results, Roth MKM analyst Eric Handler has maintained his "Buy" rating on TKO Group (TKO… [Read More]

2 days ago

Is WELL Health stock a buy? (May, 2024)

Following the company's first quarter results, Eight Capital analyst Christian Sgro thinks there is a lot of money to be… [Read More]

2 days ago

“You Never Get Fired for Buying Shopify”

Its first quarter results are in the books and ATB Capital Markets analyst Martin Toner has become bullish on Shopify… [Read More]

2 days ago